Mr. Croteau has served as a director of the Company since December 2015. Presently Mr. Croteau is the CEO of Surgical Specialties Corporation, a private equity-backed company that specializes in high performance wound closure products and surgical knives. Surgical Specialties Corporation has a global sales and marketing organization and operates manufacturing facilities in the United States, China, England, Germany, Puerto Rico, and Mexico. Mr. Croteau was the Chief Executive Officer of Vention Medical from January 2011 until March 2017, when he resigned in connection with the acquisition of Vention Medical by Nordson Corporation and the divestiture of the Vention Device Manufacturing Services business unit to MedPlast Inc. Vention Medical provides component manufacturing, assembly and design services for disposable medical devices, with fourteen facilities across the United States, Central America, Ireland and Israel. Prior to assuming his role with Vention Medical, Mr. Croteau was President of FlexMedical from July 2005 through December 2010. FlexMedical is the medical division of Flex (Nasdaq: FLEX), which provides manufacturing and supply chain services for disposable medical devices, medical equipment, and drug delivery devices. From July 2004 to June 2005, Mr. Croteau served as the Executive Vice President and General Manager of Orthopedics for Accellent (renamed Lake Region Medical in 2014 and now a division of Integer), a manufacturer of specialty components and finished medical devices used in orthopedic, cardiology, and surgical devices. From August 1999 to June 2004, Mr. Croteau served as an executive at MedSource Technologies, which was merged in June 2004 with UTI Corporation to form Accellent. As Senior Vice President at MedSource Technologies, Mr. Croteau was responsible for sales, marketing, strategy and acquisitions. Prior to entering the medical device industry in 1999, Mr. Croteau spent the majority of his career in various roles at General Electric, and working as a consultant for Booz & Company in Sydney, Australia. Mr. Croteau has a Bachelor of Science degree in mechanical engineering from the University of Vermont and a Master of Business Administration from Harvard Business School. Since May 2019, Mr. Croteau has served on the board of directors of Resonetics, a privately held micro manufacturing services company providing micro components to global medical device companies. From October 2014 to March 2018, Mr. Croteau also served as a member of the board of directors of Inventus Power, a privately held, global manufacturer of custom battery packs, chargers and portable power supply systems. As a result of these and other professional experiences, Mr. Croteau possesses knowledge and experience in manufacturing and design, particularly in the medical device industry, that strengthen the Board’s collective qualifications, skills and experience.
What is Daniel C. Croteau's net worth?
The estimated net worth of Daniel C. Croteau is at least $1.62 million as of May 10th, 2021. Mr. Croteau owns 6,431 shares of UFP Technologies stock worth more than $1,621,577 as of March 28th. This net worth evaluation does not reflect any other assets that Mr. Croteau may own. Learn More about Daniel C. Croteau's net worth.
How do I contact Daniel C. Croteau?
Has Daniel C. Croteau been buying or selling shares of UFP Technologies?
Daniel C. Croteau has not been actively trading shares of UFP Technologies during the last quarter. Most recently, on Monday, May 10th, Daniel C. Croteau bought 1,400 shares of UFP Technologies stock. The stock was acquired at an average cost of $54.98 per share, with a total value of $76,972.00. Following the completion of the transaction, the director now directly owns 6,431 shares of the company's stock, valued at $353,576.38. Learn More on Daniel C. Croteau's trading history.
Are insiders buying or selling shares of UFP Technologies?
In the last twelve months, UFP Technologies insiders bought shares 1 times. They purchased a total of 198 shares worth more than $27,522.00. In the last twelve months, insiders at the industrial products company sold shares 17 times. They sold a total of 87,327 shares worth more than $15,689,931.10. The most recent insider tranaction occured on March, 13th when VP Steve Cardin sold 311 shares worth more than $61,111.50. Insiders at UFP Technologies own 7.8% of the company.
Learn More about insider trades at UFP Technologies. Information on this page was last updated on 3/13/2024.